Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01775501
Title Sorafenib + mFOLFOX for Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Fluorouracil

Oxaliplatin

Leucovorin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02125 United States Details
Brigham and Women's Hospital Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field